Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aker BioMarine ASAOSL:AKBM -0.91%64 EBITDA Margin % is 15.71% as of Jun. 2026, which is 26% below its 10-year median of 21.09. GuruFocus rates OSL:AKBM with a GF Score™ of 64/100 and a GF Value™ of kr74.55 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,957 Consumer Packaged Goods companies, Aker BioMarine ASA ranks worse than 52.02% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aker BioMarine ASA's EBITDA for the
six
months ended in Jun. 2026 was kr173 Mil. Aker BioMarine ASA's Revenue for the
six
months ended in Jun. 2026 was kr1,104 Mil. Therefore, Aker BioMarine ASA's EBITDA margin for the quarter that ended in Jun. 2026 was 15.71%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Aker BioMarine ASA EBITDA Margin % Related Terms
Aker BioMarine ASA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Aker BioMarine ASA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:AKBM vs KHC, GIS, HRL: EBITDA Margin % Comparison
For the Packaged Foods subindustry, Aker BioMarine ASA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA (OSL:AKBM) has a EBITDA Margin % of 15.71% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aker BioMarine ASA and its competitors. This is 26% below median its historical median of 21.09. Over the past decade, Aker BioMarine ASA's EBITDA Margin % has ranged from 7.88 to 29.55. According to the industry distribution chart, Aker BioMarine ASA ranks #1018 out of 1957 companies in the Consumer Packaged Goods industry, placing it in the top 52%.
Is Aker BioMarine ASA's EBITDA Margin % too high?
Aker BioMarine ASA's current EBITDA Margin % of 15.71% is 26% below median its 10-year median of 21.09. Over the past 10 years, this metric has ranged from a low of 7.88 to a high of 29.55. The Consumer Packaged Goods industry median EBITDA Margin % is 9.00. Aker BioMarine ASA's value of 15.71% is 74.6% above this industry median. Based on the distribution chart, Aker BioMarine ASA ranks #1018 out of 1957 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Aker BioMarine ASA has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #1018 out of 1957 companies for EBITDA Margin %. This places Aker BioMarine ASA in the lower half of its industry. The industry median EBITDA Margin % is 9.00. Aker BioMarine ASA's value of 15.71% is 74.6% above this benchmark. Historically, Aker BioMarine ASA's own EBITDA Margin % has ranged from 7.88 to 29.55 over the past decade. While the company's 10-year median is 21.09 vs. the industry median of 9.00, Aker BioMarine ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.00, based on 1,957 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aker BioMarine ASA's current EBITDA Margin % of 15.71% is 74.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aker BioMarine ASA and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aker BioMarine ASA's current EBITDA Margin % is 15.71%, which is 26% below median its own 10-year median of 21.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (OSL:AKBM) is currently considered Significantly Overvalued. The stock's GF Value™ is kr74.55, compared to a current price of kr109.00 — trading 46.2% above its estimated fair value. The current EBITDA Margin % is 15.71%, which is 26% below median its 10-year median of 21.09 and 74.6% above the Consumer Packaged Goods industry median of 9.00. Aker BioMarine ASA's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aker BioMarine ASA (OSL:AKBM), the current EBITDA Margin % is 15.71% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (OSL:AKBM) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of kr109.00 is trading 46.2% above its estimated GF Value™ of kr74.55.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for OSL:AKBM:
EBITDA Margin %: 15.71% (26% below median its 10-year median of 21.09)
GF Value™: kr74.55 vs. price of kr109.00 (46.2% above fair value)
Industry Position: 74.6% above the Consumer Packaged Goods median (#1018 of 1957)
No single metric tells the full story. See the OSL:AKBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
64GF Score
Get the complete analysis for OSL:AKBM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:AKBM has been successfully added to your 
